HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Vyome Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.84−0.03 (-1.60%)
Close on Oct 19, 2026
- Market cap
- $12.91M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.44 (−65.15%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Vyome Holdings, Inc saw revenue fall 67.1% to $129.72K over the twelve months to Jun 30, 2026.
Revenue
$129.72K
-67.1% vs. a year earlier
Operating income
-$11.92M
TTM Q2 2026
EPS, diluted
-$4.86
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.91M
- P/E ratio
- –
- Price to sales
- 99.55
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $129.72K
- Net income
- -$11.31M
- EPS, diluted
- -$4.86
- Diluted shares
- 7M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$129.72K-67.1% YoY
Gross profit
$68.42K-75.4% YoY
Operating income
-$11.92M
Net income
-$11.31M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months